Kati Mokkala Selected Research

Inflammation (Inflammations)

1/2022	Distinct Diet-Microbiota-Metabolism Interactions in Overweight and Obese Pregnant Women: a Metagenomics Approach.
1/2022	Serum CathepsinD in pregnancy: Relation with metabolic and inflammatory markers and effects of fish oils and probiotics.
12/2020	The Impacts of Fish Oil and/or Probiotic Intervention on Low-Grade Inflammation, IGFBP-1 and MMP-8 in Pregnancy: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
8/2020	Early pregnancy serum IGFBP-1 relates to lipid profile in overweight and obese women.
1/2020	Distinct Metabolic Profile in Early Pregnancy of Overweight and Obese Women Developing Gestational Diabetes.
1/2020	Distinct Metabolomic Profile Because of Gestational Diabetes and its Treatment Mode in Women with Overweight and Obesity.
12/2018	Overweight and obesity status in pregnant women are related to intestinal microbiota and serum metabolic and inflammatory profiles.
9/2017	Dietary intake of fat and fibre according to reference values relates to higher gut microbiota richness in overweight pregnant women.
1/2017	Increased intestinal permeability, measured by serum zonulin, is associated with metabolic risk markers in overweight pregnant women.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kati Mokkala Research Topics

Disease

12	Overweight 05/2022 - 01/2016
9	Inflammation (Inflammations) 01/2022 - 01/2017
6	Gestational Diabetes (Gestational Diabetes Mellitus) 05/2022 - 01/2019
4	Obesity 11/2021 - 01/2017
3	Insulin Resistance 08/2020 - 01/2017
2	Weight Gain 01/2021 - 01/2019
2	Endotoxemia 12/2018 - 01/2017
1	Gestational Weight Gain 01/2021

Drug/Important Bio-Agent (IBA)

7	Fish OilsIBA 05/2022 - 01/2019
6	C-Reactive ProteinIBA 05/2022 - 01/2017
4	Insulin-Like Growth Factor Binding Protein 1IBA 05/2022 - 08/2020
4	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2017
4	LipidsIBA 11/2021 - 12/2018
3	Insulin (Novolin)FDA Link 01/2022 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2017
3	Branched-Chain Amino AcidsIBA 01/2020 - 12/2018
3	zonulinIBA 12/2018 - 01/2016
2	Eicosapentaenoic AcidIBA 05/2022 - 12/2020
2	Insulin-Like Growth Factor Binding ProteinsIBA 05/2022 - 08/2020
2	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 05/2022 - 08/2020
2	Docosahexaenoic AcidsIBA 05/2022 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2018
2	Isoleucine (L-Isoleucine)FDA Link 01/2020 - 12/2018
2	Leucine (L-Leucine)FDA Link 01/2020 - 12/2018
2	Amino Acids FDA Link 01/2020 - 12/2018
2	LipopolysaccharidesIBA 09/2017 - 01/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2022
1	Dietary Fats (Dietary Fat)IBA 01/2019
1	Adenosine Diphosphate (ADP)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2018
1	Valine (L-Valine)FDA Link 12/2018
1	Phenylalanine (L-Phenylalanine)FDA Link 12/2018
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 12/2018
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	LDL CholesterolIBA 01/2017
1	VitaminsIBA 01/2016